Godala Małgorzata, Gaszyńska Ewelina, Malecka-Wojciesko Ewa
Department of Nutrition and Epidemiology, Medical University of Lodz, 90-752 Lodz, Poland.
Department of Digestive Tract Diseases, Medical University of Lodz, 90-419 Lodz, Poland.
Nutrients. 2025 Sep 3;17(17):2858. doi: 10.3390/nu17172858.
The etiopathogenesis of IBD is not fully known; however, both genetic and environmental risk factors, including diet, are contributors to the disease. The present study aimed to determine the effect of dietary inflammatory potential, assessed using the Dietary Inflammatory Index (DII), on disease activity and inflammatory markers, such as IL-6, IL-1β, and IL-10, in patients with IBD.
The study enrolled 90 patients with IBD. Dietary intake was assessed based on a 24 h questionnaire interview conducted in each subject three times. Based on these data, the DII for each subject was calculated. The serum levels of IL-6, IL-1 β, and IL-10 were determined with the quantitative sandwich enzyme-linked immunosorbent assay (ELISA).
The mean DII value was -0.39 ± 0.52 and did not differ significantly between the groups with CD and UC (-0.42 ± 0.47 vs. -0.37 ± 0.54, = 0.6452, respectively); however, it was remarkably lower among patients in remission and with mild disease compared to those in the active phase of the disease (-0.45 ± 0.61 vs. -0.23 ± 0.65, = 0.0217). Considering the DII tertiles, the subjects differed significantly in terms of age and disease activity. Logistic regression analysis of disease severity and DII in the crude model revealed that the probability of severe disease in IBD patients increased with higher DII scores.
The results of the present study revealed a significant association between pro-inflammatory diet and IBD severity, which indicates a need to formulate an anti-inflammatory diet to reduce disease severity in patients with CD and UC.
炎症性肠病(IBD)的发病机制尚未完全明确;然而,包括饮食在内的遗传和环境风险因素都是导致该病的因素。本研究旨在确定使用饮食炎症指数(DII)评估的饮食炎症潜能对IBD患者疾病活动度和炎症标志物(如白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)和白细胞介素-10(IL-10))的影响。
本研究纳入了90例IBD患者。通过对每位受试者进行三次24小时问卷调查访谈来评估饮食摄入量。基于这些数据,计算出每位受试者的DII。采用定量夹心酶联免疫吸附测定(ELISA)法测定血清中IL-6、IL-1β和IL-10的水平。
DII的平均值为-0.39±0.52,克罗恩病(CD)组和溃疡性结肠炎(UC)组之间无显著差异(分别为-0.42±0.47和-0.37±0.54,P = 0.6452);然而,与疾病活动期的患者相比,缓解期和轻度疾病患者的DII显著更低(-0.45±0.61 vs. -0.23±0.65,P = 0.0217)。考虑DII三分位数时,受试者在年龄和疾病活动度方面存在显著差异。在原始模型中对疾病严重程度和DII进行逻辑回归分析显示,IBD患者病情严重的概率随DII评分升高而增加。
本研究结果揭示了促炎饮食与IBD严重程度之间存在显著关联,这表明需要制定抗炎饮食以降低CD和UC患者的疾病严重程度。